| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.088 | 0.06 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.094 | 0.07 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.07 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |